Business Context and Reporting Period
Company: Genworth Financial, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 1, 2011
Event Date: October 1, 2011
Genworth Financial, Inc. filed this report to disclose the completion of a material asset disposition effective October 1, 2011.
Key Financial Metrics
Transaction Value: $276 million (net of customary closing adjustments).
Assets Disposed:
- Continental Life Insurance Company of Brentwood, Tennessee.
- Subsidiary: American Continental Insurance Company.
- Reinsurance of Medicare supplement insurance in-force business written by other Genworth life insurance subsidiaries.
Pro Forma Data: The filing references unaudited pro forma condensed consolidated balance sheets as of June 30, 2011, and statements of income for the six months ended June 30, 2011, and the year ended December 31, 2010. Specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity are not provided in the text of this 8-K summary; they are contained in the referenced Exhibit 99.1.
Material Changes
The primary material change is the divestiture of the company's Medicare supplement insurance business to Aetna Inc. This transaction removes the specified subsidiaries and in-force business from Genworth's consolidated operations effective October 1, 2011.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the transaction was previously disclosed and has now been completed. No specific forward-looking guidance or outlook statements are included in the text of this report.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies arising from this specific transaction beyond the standard completion of the asset sale.
Investor Verification Checklist
- Review Exhibit 99.1 for the unaudited pro forma financial statements to understand the impact of the disposition on Genworth's balance sheet and income statement.
- Verify the final closing adjustments to confirm the net proceeds of $276 million.
- Assess the strategic rationale for exiting the Medicare supplement insurance business as previously disclosed.
- Confirm the regulatory approvals required for the transfer of the in-force business to Aetna Inc. were satisfied.